29100987|t|Istradefylline reduces memory deficits in aging mice with amyloid pathology.
29100987|a|Adenosine A2A receptors are putative therapeutic targets for neurological disorders. The adenosine A2A receptor antagonist istradefylline is approved in Japan for Parkinson's disease and is being tested in clinical trials for this condition elsewhere. A2A receptors on neurons and astrocytes may contribute to Alzheimer's disease (AD) by impairing memory. However, it is not known whether istradefylline enhances cognitive function in aging animals with AD-like amyloid plaque pathology. Here, we show that elevated levels of Abeta, C-terminal fragments of the amyloid precursor protein (APP), or amyloid plaques, but not overexpression of APP per se, increase astrocytic A2A receptor levels in the hippocampus and neocortex of aging mice. Moreover, in amyloid plaque-bearing mice, low-dose istradefylline treatment enhanced spatial memory and habituation, supporting the conclusion that, within a well-defined dose range, A2A receptor blockers might help counteract memory problems in patients with Alzheimer's disease.
29100987	0	14	Istradefylline	Chemical	MESH:C111599
29100987	23	38	memory deficits	Disease	MESH:D008569
29100987	48	52	mice	Species	10090
29100987	58	75	amyloid pathology	Disease	MESH:C000718787
29100987	87	90	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
29100987	138	160	neurological disorders	Disease	MESH:D009461
29100987	179	188	 receptor	Gene	11540
29100987	176	179	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
29100987	200	214	istradefylline	Chemical	MESH:C111599
29100987	240	259	Parkinson's disease	Disease	MESH:D010300
29100987	329	332	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
29100987	387	406	Alzheimer's disease	Disease	MESH:D000544
29100987	408	410	AD	Disease	MESH:D000544
29100987	466	480	istradefylline	Chemical	MESH:C111599
29100987	531	533	AD	Disease	MESH:D000544
29100987	539	553	amyloid plaque	Disease	MESH:D058225
29100987	603	608	Abeta	Gene	11820
29100987	638	663	amyloid precursor protein	Gene	11820
29100987	674	689	amyloid plaques	Disease	MESH:D058225
29100987	749	752	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
29100987	811	815	mice	Species	10090
29100987	830	844	amyloid plaque	Disease	MESH:D058225
29100987	853	857	mice	Species	10090
29100987	868	882	istradefylline	Chemical	MESH:C111599
29100987	1000	1003	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
29100987	1051	1059	problems	Disease	MESH:D019973
29100987	1063	1071	patients	Species	9606
29100987	1077	1096	Alzheimer's disease	Disease	MESH:D000544
29100987	Negative_Correlation	MESH:C111599	HGVS:c.2A>A;CorrespondingGene:351
29100987	Association	HGVS:c.2A>A;CorrespondingGene:351	MESH:D009461
29100987	Negative_Correlation	MESH:C111599	11540
29100987	Positive_Correlation	HGVS:c.2A>A;CorrespondingGene:351	MESH:D058225
29100987	Association	HGVS:c.2A>A;CorrespondingGene:351	MESH:D019973
29100987	Association	HGVS:c.2A>A;CorrespondingGene:351	MESH:D000544
29100987	Negative_Correlation	MESH:C111599	MESH:C000718787
29100987	Negative_Correlation	MESH:C111599	MESH:D010300
29100987	Negative_Correlation	MESH:C111599	MESH:D008569
29100987	Association	MESH:D009461	351
29100987	Association	MESH:D058225	351
29100987	Association	MESH:D019973	351
29100987	Association	MESH:D000544	351

